Ideaya Biosciences Inc (IDYA) — Financial Flexibility Index
Ideaya Biosciences Inc (IDYA) has a Financial Flexibility Index of -1.46x as of June 2026. Free cash flow of $-161.55 Million (operating CF $-163.38 Million minus capex $1.83 Million) represents -1% of total liabilities ($110.79 Million). Check IDYA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ideaya Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Ideaya Biosciences Inc across 9 annual periods. For the full cash flow conversion analysis, see Ideaya Biosciences Inc cash flow conversion.
Annual Financial Flexibility Index for Ideaya Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Ideaya Biosciences Inc. Explore how well can Ideaya Biosciences Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.80x | $-68.73 Million | $-71.10 Million | $86.39 Million | ▲ +78.8% |
| 2024 | -3.75x | $-243.73 Million | $-247.58 Million | $64.94 Million | ▲ +6.1% |
| 2023 | -4.00x | $-112.86 Million | $-115.22 Million | $28.23 Million | ▼ -83.9% |
| 2022 | -2.17x | $-83.73 Million | $-87.17 Million | $38.51 Million | ▼ -226.6% |
| 2021 | -0.67x | $-53.13 Million | $-55.78 Million | $79.83 Million | ▼ -218.9% |
| 2020 | 0.56x | $55.96 Million | $55.46 Million | $100.00 Million | ▲ +118.6% |
| 2019 | -3.01x | $-37.96 Million | $-39.31 Million | $12.60 Million | ▼ -1591.4% |
| 2018 | -0.18x | $-25.91 Million | $-27.62 Million | $145.49 Million | ▲ +43.5% |
| 2017 | -0.32x | $-10.47 Million | $-12.22 Million | $33.22 Million | — |